Rallybio Corp Form 8-K Summary
Business Context and Reporting Period
Rallybio Corporation (RLYB), an emerging growth company incorporated in Delaware, filed this Current Report on Form 8-K on May 15, 2024. The filing details the results of the company's annual meeting of shareholders held on the same date.
Key Financial Metrics
This filing does not contain financial performance data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes and Voting Results
The primary event reported is the outcome of shareholder votes at the annual meeting:
- Board of Directors Election: Shareholders elected four Class III directors for terms expiring in 2027. Hui Liu received the highest support with 26,568,854 votes "For," while Wendy K. Chung, Robert Hopfner, and Ronald Hunt each received approximately 19.7 million "For" votes. All nominees were elected.
- Accounting Firm Ratification: Shareholders ratified the appointment of Deloitte and Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, with 31,396,236 votes "For."
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, or details on contingencies and unusual items.
Investor Verification Checklist
- Verify the composition of the newly elected Board of Directors and their terms.
- Confirm the ratification of Deloitte and Touche LLP as the auditor for the 2024 fiscal year.
- Review the company's most recent 10-Q or 10-K for financial metrics, as this 8-K contains no financial data.